HC9 Ventures is a healthcare-focused venture capital firm that partners with founders to scale and monetize emerging value-added healthcare businesses by providing capital and industry expertise. The firm invests in early-stage healthcare software and services companies, drawing on a community of over 125 healthcare leaders as its exclusive source of capital.
84% of their portfolio is in Healthcare. Deal activity decreased year-over-year (2 deals in the last 12 months vs 3 prior). Their most common stage is series-a (53% of deals). Average disclosed round size is $19.0M (across 16 rounds with reported amounts).
Portfolio
10
Fund Size
—
Top Stage
Series A
Last 12 Mo
2
Team
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
19 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series A | $17.5M | May 2026 | |
| Series A | $17.5M | Jan 2026 | |
| Seed | — | Jan 2026 | |
| Series A | $17.5M | Jan 2026 | |
| Series A | $17.5M | Jan 2026 | |
| Series B | $19M | Dec 2025 | |
| Seed | — | Jan 2025 | |
| Series A | $7.5M | Oct 2024 | |
| Series B | $33.2M | Sep 2024 | |
| Series B | $33.2M | Sep 2024 | |
| Series B | $33.2M | Jan 2024 | |
| Series A | $15M | May 2023 | |
| Series A | $17.1M | Sep 2022 | |
| Unknown | $16M | Aug 2022 | |
| Series A | $17.1M | Jan 2022 | |
| Series A | $17.1M | Jan 2021 | |
| Series A | $15M | — | |
| Growth | $11M | — | |
| Seed | — | — |
Top Co-Investors
Valor Equity Partners6 shared
American Family Ventures5 shared
Salesforce Ventures4 shared
Matrix Partners4 shared
Susa Ventures4 shared
Plug and Play Tech Center3 shared
ManchesterStory Group3 shared
SemperVirens Venture Capital3 shared
QED Investors3 shared
Village Global2 shared
Core Innovation Capital2 shared
GSR Ventures2 shared
MaC Venture Capital2 shared
Canvas Prime1 shared
Frist Cressey Ventures1 shared
Emerson Collective1 shared
Maverick Ventures1 shared
Khosla Ventures1 shared
LRVHealth1 shared
Optum Ventures1 shared
Last updated: 7 October 2026
